Skip to main content
    G

    Greenwich Lifesciences Inc (GLSI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $15.32
    -0.08 (-0.52%)

    Market Cap: $226.04M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    71%(17/24)
    Avg Surprise
    -0.33%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.34
    Range$-0.37 - $-0.30
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$-0.340.0%
    60d ago$-0.340.0%
    30d ago$-0.37+9.5%
    7d ago$-0.37+9.5%
    Current$-0.34
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.37
    Range$-0.47 - $-0.28
    2 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.37---
    Sep 26EST
    		-$-0.34---
    Jun 26
    Reported Aug 11
    		$-0.27$-0.33+18.18%Beat+10.0%
    Mar 26
    Reported Jun 3
    		$-0.39$-0.32-21.88%Miss-56.0%
    Dec 25
    Reported Mar 31
    		$-0.58$-0.34-70.59%Miss+4.9%
    Sep 25
    Reported Nov 14
    		$-0.30$-0.36+16.67%Beat-50.0%
    Jun 25
    Reported Aug 14
    		$-0.30$-0.24-25.00%Miss-50.0%
    Mar 25
    Reported Apr 15
    		$-0.25$-0.24-4.17%Miss-31.6%
    Dec 24
    Reported Feb 26
    		$-0.61$-0.21-190.48%Miss-185.3%
    Sep 24
    Reported Nov 14
    		$-0.20$-0.21+4.76%Beat-5.3%
    Jun 24
    Reported Aug 14
    		$-0.20$-0.20+0.00%Beat-53.8%
    Mar 24
    Reported Apr 15
    		$-0.19$-0.20+5.00%Beat-11.8%
    Dec 23
    Reported Mar 31
    		$-0.21$-0.22+2.82%Beat+2.8%
    Sep 23
    Reported Oct 19
    		$-0.19$-0.22+13.64%Beat-5.6%
    Jun 23
    Reported Aug 21
    		$-0.13$-0.23+43.48%Beat-116.7%
    Mar 23
    Reported May 22
    		$-0.17$-0.23+26.09%Beat-13.3%
    Dec 22
    Reported Mar 31
    		$-0.22$-0.22+0.00%Beat-22.2%
    Sep 22
    Reported Nov 14
    		$-0.18$-0.19+5.26%Beat-157.1%
    Jun 22
    Reported Aug 15
    		$-0.06N/A+68.42%Beat+0.0%
    Mar 22
    Reported May 20
    		$-0.15$-0.19+21.05%Beat-200.0%
    Dec 21
    Reported Mar 21
    		$-0.18$-0.07-157.14%Miss-50.0%
    Sep 21
    Reported Nov 15
    		$-0.07$-0.06-16.67%Miss-133.3%
    Jun 21
    Reported Aug 13
    		$-0.06N/A+81.25%Beat-200.0%
    Mar 21
    Reported May 20
    		$-0.05N/A+84.38%Beat-150.0%
    Dec 20
    Reported Mar 31
    		$-0.12N/A+87.10%Beat+55.6%
    Sep 20
    Reported Nov 16
    		$-0.03$-0.03+0.00%Beat+97.4%
    Jun 20
    Reported Sep 28
    		$-0.02$0.00N/AMiss+99.8%
    Mar 20
    Reported Jun 23
    		$-0.02$0.00N/AMiss+97.3%
    Dec 19
    Reported Jan 28
    		$-0.27$0.00N/AMiss-
    Jun 19
    Reported Sep 30
    		$-1.15$0.00N/AMiss-
    Mar 19
    Reported Jun 29
    		$-12.83$0.00N/AMiss-
    Dec 18
    Reported Mar 30
    		$-0.73$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-9.95EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-986.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio1.54xQuick Ratio1.54x
    Trading Statistics
    Beta1.46Avg Volume143.02K
    52-Week High$34.1052-Week Low$7.78

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$16.07
    SMA 20$17.20
    SMA 50$16.63
    SMA 200$21.93
    EMA 10$16.16
    EMA 20$16.53
    EMA 50$16.96
    EMA 200$18.51

    MACD

    Line: -0.33Signal: -0.09Hist: -0.24

    ADX

    ADX: 16.3+DI: 17.9-DI: 25.2

    Aroon & PSAR

    Aroon Up32.0
    Aroon Down92.0
    PSAR$17.31

    Bollinger Bands

    Upper Band$19.97
    Lower Band$14.43
    %B Position3221%(Upper)
    Band Width0.16

    RSI (14-Day)

    Neutral
    42.9

    Momentum Oscillators

    Stoch %K25.7
    Stoch %D36.2
    Williams %R-76.0
    ROC (10d)-11.7%
    Momentum-2.03
    CCI (20d)-113.0
    MFI (14d)23.9

    Volatility Measures

    ATR (14d)$1.49(9.7%)
    StdDev (20d)1.38
    Hist Vol83.5%(High)

    Volume Flow

    VWAP$15.33
    OBV8.1M
    AD Line-11.6M
    CMF (20d)-0.178

    Volume Metrics

    Avg Vol (20d)138.9K
    Vol Ratio0.6x
    VWMA (20d)$17.14

    Pivot Points

    R3$17.32
    R2$16.83
    R1$16.12
    Pivot Point$15.63
    S1$14.92
    S2$14.43
    S3$13.72

    Advanced Oscillators

    TSI-6.65
    Ultimate Osc46.0
    KST-21.18

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0N/A$0$0$0N/A$0$0$0N/A$0
    Gross Profit$0$0N/A$0$0$0N/A$0$0$0N/A$0
    Operating Expenses$4.02M$5.73M$7.94M$4.17M$3.77M$2.77M$9.71M$2.73M$2.66M$2.54M$2.84M$2.50M
    R&D$3.56M$5.21M$7.59M$3.52M$3.42M$2.27M$8.69M$2.29M$2.31M$2.19M$2.33M$2.16M
    SG&A$462,931$518,190$355,194$653,066$352,838$497,602$1.02M$437,011$353,531$342,688$503,052$344,758
    Operating Income$-4,021,645$-5,725,754$-7,944,991$-4,174,642$-3,769,315$-2,768,750$-9,709,571$-2,729,051$-2,661,404$-2,537,201$-2,836,033$-2,502,925
    Interest Income$72,970$68,617$22,258$22,797$20,675$23,970$43,942$60,338$54,722$64,006$89,294$111,136
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-3,948,675$-5,657,137$-7,922,733$-4,151,845$-3,748,640$-2,744,780$-9,665,629$-2,668,713$-2,606,682$-2,473,195$-2,746,739$-2,391,789
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-3,948,675$-5,657,137$-7,922,733$-4,151,845$-3,748,640$-2,744,780$-9,665,629$-2,668,713$-2,606,682$-2,473,195$-2,746,739$-2,391,789
    EBITDA$-4,021,645$-5,725,754$-7,944,991$-4,174,642$-3,768,439$-2,767,847$-9,708,668$-2,728,148$-2,660,501$-2,536,298$-2,835,130$-2,502,022
    EBIT$-4,021,645$-5,725,754$-7,944,991$-4,174,642$-3,769,315$-2,768,750$-9,709,571$-2,729,051$-2,661,404$-2,537,201$-2,836,033$-2,502,925
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about GLSI

    News

    Precision Trading with Greenwich Lifesciences Inc. (GLSI) Risk Zones

    This article provides a detailed analysis of Greenwich Lifesciences Inc. (GLSI), highlighting a weak near and mid-term sentiment but a strong long-term outlook. It outlines three AI-generated trading strategies—Position...

    Stock Traders Daily•10/12/26•Somewhat-Bullish

    Greenwich LifeSciences (NASDAQ:GLSI) Posts Quarterly Earnings Results

    Greenwich LifeSciences (NASDAQ:GLSI) announced its quarterly earnings, reporting a loss of $0.27 per share, which exceeded analyst expectations of a $0.33 loss. The company's stock traded around $15.55...

    MarketBeat•8/11/26•Neutral

    Greenwich LifeSciences 2Q 2026: Revenue $0 Net loss $(3.95M), EPS $(0.27) — 10-Q Summary

    Greenwich LifeSciences (GLSI) reported no product revenue for Q2 2026, consistent with the prior year. The company posted a net loss of $(3.95M), or $(0.27) per diluted share...

    TradingView•8/11/26•Neutral

    Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027

    Greenwich LifeSciences (GLSI) has extended the lock-up period for shares owned by its directors, officers, and pre-IPO investors until January 31, 2027. This decision aims to support strategic and financing transactions...

    GlobeNewswire•8/10/26•Bullish

    Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027

    Greenwich LifeSciences, Inc. (Nasdaq: GLSI) has announced an extension of the lock-up period for shares owned by its directors, officers, and pre-IPO investors until January 31...

    The Manila Times•8/10/26•Somewhat-Bullish

    GLSI Valuation and Fair Value

    P/E
    -9.9x
    P/B
    71.9x
    See GNG's fair value

    GLSI Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -986.0%

    GLSI Competitors

    CompanyTicker
    Sol Gel Technologies LtdSLGL
    Spok Holdings IncSPOK
    Zentalis Pharmaceuticals LlcZNTL
    SIGA Technologies IncSIGA
    Electromed IncELMD
    Pyxis Oncology IncPYXS
    Lineage Cell Therapeutics IncLCTX
    InflaRx N.V.IFRX

    Sector: Healthcare

    GLSI Bull Case vs Bear Case

    Bear case

    • GLSI beat EPS estimates in 37.5% of its last 8 reported quarters.

    GLSI Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -34.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.34
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About GLSI

    Does GLSI pay dividends?

    Greenwich Lifesciences Inc (GLSI) does not currently pay a regular dividend.

    What is GLSI's market cap?

    Greenwich Lifesciences Inc (GLSI) has a market capitalization of $226.04M with a current stock price of $15.32.

    Related stocks

    Sector: Healthcare

    All stocks starting with G

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In